NDAORALTABLET
Approved
Oct 2003
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
2
Clinical Trials (2)
Boosted Lexiva With Lovaza Adjunctive Therapy in Hypertriglyceridemic, HIV-Infected Subjects
Started Sep 2009
36 enrolled
HypertriglyceridemiaHIV Infection
KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks
Started May 2004
866 enrolled
HIV InfectionInfection, Human Immunodeficiency Virus